Over the last few months, our firm has been keeping readers updated on the Risperdal cases we have been litigating in Philadelphia. We just won a verdict for the Yount family. Their son grew female breasts at age 5 due to Risperdal, a now-infamous antipsychotic.
Our client, now a young man, wanted to hold Janssen Pharmaceuticals (a subsidiary of Johnson & Johnson) accountable for their actions—specifically, their failure to accurately inform doctors of a known link between gynecomastia and Risperdal use. As our client began taking the medication before the effects were publicized, he suffered from gynecomastia before his parents fully understood the risk.
After thorough preparation and relentless pursuit of justice, Attorneys Jason Itkin, Kyle Findley, Ces Taveres, and Cory Itkin have successfully obtained a verdict for this young man. A Philadelphia jury unanimously found Janssen responsible, ordering them to pay our client $76 million for his medical costs, physical damages, and emotional suffering.
Our firm is not only pleased with this result—we are pleased that our work may be able to help give hope to other suffering patients that they too may receive the compensation they deserve. The people of Philadelphia clearly saw that Johnson & Johnson behaved irresponsibly in pushing their drug into the children’s market before it could be thoroughly tested and approved, and behaved even more irresponsibly when they downplayed the risk of gynecomastia
We are happy our client received a just verdict. If you have developed breast deformities after taking Risperdal, contact our team.